1 min read

How to Advance your Oncology Compound to Success

By JoAnn Eckhoff

Veristat-Cancer-CRO

Oncology Expertise to Advance your Compound

Choose Veristat to be your collaborative partner to develop novel cancer therapies and let us provide you with key planning and development guidance. Veristat can guide you through the planning and development process to help you successfully bring a new cancer treatment to market. Our teams will collaborate to design an optimal program, while providing key functional services, including trial design, protocol writing, and statistical consultation with regulatory representation.

Our Goals for Your Program:

  • Ensure innovative trial designs are based upon informed decisions
  • Incorporate best practices to reduce the need for change orders
  • Maximize quality and compliance
  • Ensure accountability in meeting milestones to avoid extended timelines
  • Maximize communication practices to achieve success within each aspect of the trial

Veristat Understands the Oncology Landscape and our Teams work Diligently to:

  • Maintain a deep understanding of cancer trends, data, standards, and key statistical methods
  • Incorporate methods that reduce common study delays
  • Engage with physicians and research staff on recruitment efforts
  • Collaborate with each client to ensure trials are well designed and compatible with current practice standards of care
  • Tap into Veristat expertise across functional teams in clinical data management, clinical monitoring, statistical programming, biostatistics, medical writing, and regulatory submissions

Trust Veristat to Drive Your Compound’s Success with Complete, Precise, and Timely Regulatory Documents

With 20 years of comprehensive medical writing experience, you can rely on Veristat at any point in the product development lifecycle for complete, precise, and timely support. From a clinical development plan and investigator brochure to your regulatory submission documents, Veristat’s in-house team will complement your efforts. We understand the complexities of the approval process and the importance of presenting accurate and substantial evidence to support the key conclusions of your development program. Working closely with you at every stage, Veristat will custom-build your documents to meet the complex requirements of your product, therapeutic indication, and the applicable regulatory agencies.

For more information on Veristat, and our services, please contact info@veristat.com.

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...

1 min read

Swiss Biotech Day

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

With nearly 30 years of experience in clinical trial...